Home M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down
 

Keywords :   


M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down

2015-12-14 20:08:05| Biotech - Topix.net

Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty.

Tags: small slowing midcap biotechs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11 24.525.5cm
25.11 B
25.11SHIMANO CS-R8000 14-28t 1
25.11RADWIMPS/
25.11Delegation Delegation
25.11009 19685DVD
25.1124 C2000S
25.11stayc applemusic so bad 1
More »